Verified earnings results
enGene Therapeutics Q3 2026 Earnings Results
Direct answer
enGene Therapeutics reported Q3 2026 results on September 8, 2026.
Revenue was 0. EPS missed the estimate by 7.16%.
The result is verified against Verified earnings source.
Verified earnings source
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- September 8, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.4386
- Reported EPS
- -0.47
- Revenue
- 0
- EPS surprise
- EPS missed the estimate by 7.16%.
Explore related company data
Read the frequently asked questions.
When did enGene Therapeutics report Q3 2026 earnings?
enGene Therapeutics reported on September 8, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for enGene Therapeutics?
The verified record provides an EPS estimate of -0.4386.
Has enGene Therapeutics reported the Q3 2026 result?
Revenue was 0. EPS missed the estimate by 7.16%.
Which source supports this enGene Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.